Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia

Clinical trial NCT02658487 · COMPLETED

Trial details

NCT number: NCT02658487
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia With Multilineage Dysplasia Myeloid Sarcoma Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Therapy-Related Myelodysplastic Syndrome

Start date: 2016-03-01
Primary completion: 2019-04-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.